Conference on personalised cancer therapy

Barcelona: 3-4 December 2012

The organisers of the IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine – Manel Esteller, George Thomas, Cristina Muñoz- Pinedo and Sara Kozma – will present 21speakers for the event, all leading oncologists and cancer researchers, particularly those working in the study of genetic and epigenetic defects leading to the selection of cancer patients for new drug therapies. The meeting aims to highlight the latest understanding of biological mechanisms and natural history of cancer, thus providing novel targets for therapy, as well as to discuss the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. Special focus: Epigenetics and DNA Repair and the metabolism and cell signalling areas with the updated clinical applications. Details: http://bocemtium.com

05.11.2012

News • Transcriptomic atlas

Breast cancer map: charting the course for precision oncology

A molecular map of breast cancer identifies novel forms and provides a foundation for personalized treatments guided by a tumor’s molecular characteristics rather than standard pathology alone.

Taipei Brings Six Biomedical Innovations to MEDICA 2026

Six Taipei-based biomedical companies will showcase innovations in precision medicine and smart healthcare at MEDICA 2026 (November 16–19, Düsseldorf).

News • Preclinical study

Lung cancer: new approach to reduce radiation-related damage

Radiotherapy can be lifesaving for patients with lung cancer, but may also damage healthy lung tissue and limit future treatments. Discovery of a new immune pathway could help prevent this damage.